ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,012Medicare Part D Prescriptions Filled, Including Refills

Rank: 68 out of 298

$432K Total Retail Price of All Prescriptions

Rank: 47 out of 298

406 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 406 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 406 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 5,353 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
OMEPRAZOLE 293 225 1 3
LEVOTHYROXINE SODIUM 252 215 2 1
LISINOPRIL 245 206 3 4
SIMVASTATIN 243 211 4 2
HYDROCODONE-ACETAMINOPHEN 163 122 S3 5 8
POTASSIUM CHLORIDE 145 127 6 11
TRAMADOL HCL 139 87 7 15
FUROSEMIDE 135 124 8 5
WARFARIN SODIUM 130 97 9 7
PREDNISONE 119 96 10 33
ZOLPIDEM TARTRATE 110 71 11 25
ATORVASTATIN CALCIUM 108 93 12 14
METFORMIN HCL 105 68 13 10
SPIRONOLACTONE 100 81 14 34
AMLODIPINE BESYLATE 98 97 15 6
CYMBALTA 91 17 16 67
METOPROLOL TARTRATE 84 72 17 9
NEXIUM 83 60 18 40
OXYCONTIN 81 47 S2 19 162
DONEPEZIL HCL 79 79 20 22
METOPROLOL SUCCINATE 78 53 21 12
HYDROCHLOROTHIAZIDE 78 58 21 13
DIGOXIN 76 75 23 27
CARVEDILOL 70 70 24 23
TAMSULOSIN HCL 66 50 25 24
LIDODERM 64 61 26 161
PAROXETINE HCL 61 53 27 48
ALLOPURINOL 61 56 27 28
NAMENDA 59 59 29 35
GABAPENTIN 58 33 30 20
LISINOPRIL-HYDROCHLOROTHIAZIDE 58 52 30 30
CITALOPRAM HBR 55 51 32 17
TRAZODONE HCL 54 29 33 39
FLUTICASONE PROPIONATE 53 39 34 38
RISPERIDONE 53 44 34 54
VENLAFAXINE HCL ER 52 34 36 90
MELOXICAM 52 42 36 41
LOVAZA 51 12 38 188
CYCLOBENZAPRINE HCL 51 30 R 38 100
LOSARTAN POTASSIUM 51 49 38 18
PREMARIN 50 49 R 41 110
SPIRIVA 50 34 41 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 23, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.